Please use this identifier to cite or link to this item:
http://hdl.handle.net/11452/25135
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.date.accessioned | 2022-03-17T11:20:43Z | - |
dc.date.available | 2022-03-17T11:20:43Z | - |
dc.date.issued | 2010-06 | - |
dc.identifier.citation | Türkkan, A. vd. (2010). "Citicoline and postconditioning provides neuroprotection in a rat model of ischemic spinal cord injury". Acta Neurochirurgica, 152(6), 1033-1042. | en_US |
dc.identifier.issn | 0001-6268 | - |
dc.identifier.issn | 0942-0940 | - |
dc.identifier.uri | https://doi.org/10.1007/s00701-010-0598-5 | - |
dc.identifier.uri | https://link.springer.com/article/10.1007/s00701-010-0598-5 | - |
dc.identifier.uri | http://hdl.handle.net/11452/25135 | - |
dc.description.abstract | Ischemic spinal cord injury is a chain of events caused by the reduction and/or cessation of spinal cord blood flow, which results in neuronal degeneration and loss. Ischemic postconditioning is defined as a series of intermittent interruptions of blood flow in the early phase of reperfusion and has been shown to reduce the infarct size in cerebral ischemia. Our study aimed to characterize the relationship between the neuronal injury-decreasing effects of citicoline and ischemic postconditioning, which were proven to be effective against the apoptotic process. Spinal cord ischemia was produced in rats using an intrathoracic approach to implement the synchronous arcus aorta and subclavian artery clipping method. In our study, 42 male Sprague-Dawley rats (309 +/- 27 g) were used. Animals were divided into sham operated, spinal ischemia, citicoline, postconditioning, and postconditioning citicoline groups. Postconditioning was generated by six cycles of 1 min occlusion/5 min reperfusion. A 600 mmol/kg dose of citicoline was given intraperitoneally before ischemia in the citicoline and postconditioning citicoline groups. All rats were sacrificed 96 h after reperfusion. For immunohistochemical analysis, bcl-2, caspase 3, caspase 9, and bax immune staining were performed. Caspase 3, caspase 9, bax, and bcl-2 were used as apoptotic and antiapoptotic markers, respectively. The blood pressure values obtained at the onset of reperfusion were significantly lower than the preischemic values. A difference in immunohistochemical scoring was detected between the caspase 3, caspase 9, bax, and bcl-2 groups. When comparisons between the ischemia (groups 2, 3, 4, and 5) and sham groups (group 1) were performed, a significant increase in caspase 3, caspase 9, bax, and bcl-2 was detected. When comparing the subgroups, the average score of caspase 9 was found to be significantly higher in ischemia group 2. The average score of bcl-2 was also found to be significantly higher in postconditioning and citicoline group 5. It is thus thought that combining citicoline with postconditioning provides protection by inhibiting the caspase pathway and by increasing the antiapoptotic proteins. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Springer Wien | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Apoptosis | en_US |
dc.subject | Citicoline | en_US |
dc.subject | Postconditioning | en_US |
dc.subject | Spinal cord ischemia | en_US |
dc.subject | Cerebrospinal-fluid drainage | en_US |
dc.subject | CDP-choline | en_US |
dc.subject | Reperfusion injury | en_US |
dc.subject | Cerebral-ischemia | en_US |
dc.subject | Thoracoabdominal aorta | en_US |
dc.subject | Focal ischemia | en_US |
dc.subject | Circulatory arrest | en_US |
dc.subject | Caspase activation | en_US |
dc.subject | Aneurysm repair | en_US |
dc.subject | Brain-damage | en_US |
dc.subject | Neurosciences & neurology | en_US |
dc.subject | Surgery | en_US |
dc.subject.mesh | 1-phosphatidylinositol 4-kinase | en_US |
dc.subject.mesh | Algorithms | en_US |
dc.subject.mesh | Animals | en_US |
dc.subject.mesh | Apoptosis | en_US |
dc.subject.mesh | Bcl-2-associated X protein | en_US |
dc.subject.mesh | Caspase 3 | en_US |
dc.subject.mesh | Caspase 9 | en_US |
dc.subject.mesh | Cytidine diphosphate choline | en_US |
dc.subject.mesh | Enzyme activation | en_US |
dc.subject.mesh | Ischemic preconditioning | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Motor neurons | en_US |
dc.subject.mesh | Neuroprotective agents | en_US |
dc.subject.mesh | Nootropic agents | en_US |
dc.subject.mesh | Oxidative stress | en_US |
dc.subject.mesh | Proto-oncogene proteins c-bcl-2 | en_US |
dc.subject.mesh | Rats | en_US |
dc.subject.mesh | Rats, sprague-dawley | en_US |
dc.subject.mesh | Reperfusion injury | en_US |
dc.subject.mesh | Spinal cord | en_US |
dc.subject.mesh | Spinal cord ischemia | en_US |
dc.title | Citicoline and postconditioning provides neuroprotection in a rat model of ischemic spinal cord injury | en_US |
dc.type | Article | en_US |
dc.identifier.wos | 000277783300014 | tr_TR |
dc.identifier.scopus | 2-s2.0-77953020224 | tr_TR |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Beyin ve Sinir Cerrahisi Anabilim Dalı. | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Fizyoloji Anabilim Dalı. | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Tıbbi Patoloji Anabilim Dalı. | tr_TR |
dc.identifier.startpage | 1033 | tr_TR |
dc.identifier.endpage | 1042 | tr_TR |
dc.identifier.volume | 152 | tr_TR |
dc.identifier.issue | 6 | tr_TR |
dc.relation.journal | Acta Neurochirurgica | en_US |
dc.contributor.buuauthor | Türkkan, Alper | - |
dc.contributor.buuauthor | Alkan, Tülin | - |
dc.contributor.buuauthor | Gören, Bülent | - |
dc.contributor.buuauthor | Kocaeli, Hasan | - |
dc.contributor.buuauthor | Akar, Eylem | - |
dc.contributor.buuauthor | Korfali, Ender | - |
dc.contributor.researcherid | AAH-1792-2021 | tr_TR |
dc.contributor.researcherid | AAH-1718-2021 | tr_TR |
dc.identifier.pubmed | 20112033 | tr_TR |
dc.subject.wos | Clinical neurology | en_US |
dc.subject.wos | Surgery | en_US |
dc.indexed.wos | SCIE | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.pubmed | Pubmed | en_US |
dc.wos.quartile | Q2 (Surgery) | en_US |
dc.wos.quartile | Q3 (Clinical neurology) | en_US |
dc.contributor.scopusid | 25029159600 | tr_TR |
dc.contributor.scopusid | 6601953747 | tr_TR |
dc.contributor.scopusid | 6602543716 | tr_TR |
dc.contributor.scopusid | 6603500567 | tr_TR |
dc.contributor.scopusid | 26634688200 | tr_TR |
dc.contributor.scopusid | 7004641343 | tr_TR |
dc.subject.scopus | Thoracic Aorta Aneurysm; Spinal Cord Ischemia; Endoleak | en_US |
dc.subject.emtree | Biological marker | en_US |
dc.subject.emtree | Caspase 3 | en_US |
dc.subject.emtree | Caspase 9 | en_US |
dc.subject.emtree | Citicoline | en_US |
dc.subject.emtree | Protein bax | en_US |
dc.subject.emtree | Protein bcl 2 | en_US |
dc.subject.emtree | Animal experiment | en_US |
dc.subject.emtree | Animal model | en_US |
dc.subject.emtree | Animal tissue | en_US |
dc.subject.emtree | Aorta arch | en_US |
dc.subject.emtree | Apoptosis | en_US |
dc.subject.emtree | Artery clamp | en_US |
dc.subject.emtree | Article | en_US |
dc.subject.emtree | Blood pressure | en_US |
dc.subject.emtree | Controlled study | en_US |
dc.subject.emtree | Immunohistochemistry | en_US |
dc.subject.emtree | Ischemic preconditioning | en_US |
dc.subject.emtree | Male | en_US |
dc.subject.emtree | Neuroprotection | en_US |
dc.subject.emtree | Nonhuman | en_US |
dc.subject.emtree | Priority journal | en_US |
dc.subject.emtree | Rat | en_US |
dc.subject.emtree | Reperfusion | en_US |
dc.subject.emtree | Scoring system | en_US |
dc.subject.emtree | Spinal cord injury | en_US |
dc.subject.emtree | Spinal cord ischemia | en_US |
dc.subject.emtree | Subclavian artery | en_US |
Appears in Collections: | PubMed Scopus Web of Science |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.